The importance of the clinical trialing process in the development of modern-day drugs

Alan Ying

doi:10.1117/12.2669042

24 March 2023 The importance of the clinical trialing process in the development of modern-day drugs

Alan Ying

Proceedings Volume 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022); 1261166 (2023) https://doi.org/10.1117/12.2669042
Event: International Conference on Biological Engineering and Medical Science (ICBioMed2022), 2022, Oxford, United Kingdom

Abstract

The drug development process for a single drug can be extremely costly, extensive, and arduous. Furthermore, approximately only 14% of drugs as of recent during the clinical trial process make it through the process and obtain FDA approval, making the clinical trial process very daunting for pharmaceutical researchers. The clinical trial process is very important in confirming that a novel drug’s safety and efficacy when administered is mirrored in both human clinical studies and animal preclinical studies. Furthermore, understanding the current frameworks, techniques, and study designs that allow for a better assessment of a novel drug’s safety and efficacy can help make the clinical trial process smoother and a better basis for the future optimization of current clinical procedures. Finally, collecting and analyzing important data while interpreting it correctly is crucial in making sure that a novel drug treatment is as safe and effective as it can be at a specific dosage. This paper is important, for it focuses on mitigating any shortcomings or problems in the clinical trial process that might prevent the drug from ever reaching FDA approval. The paper does this by highlighting the important and successful aspects of the clinical trial process that can help solidify and optimize a novel drug treatment as safe and effective for FDA approval.

Citation Download Citation

Alan Ying "The importance of the clinical trialing process in the development of modern-day drugs", Proc. SPIE 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022), 1261166 (24 March 2023); https://doi.org/10.1117/12.2669042

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available